MUMBAI – India’s deal street looks set for brisk activity this year across biomedical-related firms. Investment bankers see high interest in large health care-related brands outside of price controls launched last year, as well as medical devices priced for the middle class and contract manufacturing operations.
All of these areas are seen by strategic and financial investors as an opportunity to catch the next leg of...
Welcome to HBW Insight
Create an account to read this article
Already a subscriber?